Related Experiment Videos
Chemotherapy induced myocardial fibrosis
M P Callaway1, C J Tyrrell, M P Williams
1Manchester Royal Infirmary, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|January 1, 1994
Summary
Some patients show unexpected susceptibility to alkylating agents, leading to drug-induced pneumonitis. Early screening of left ventricular function is crucial for diagnosing myocardial fibrosis and preventing cardiac failure.
Area of Science:
- Oncology
- Cardiology
- Toxicology
Background:
- Alkylating agents are standard treatments for malignant diseases.
- These agents have known, documented side effects.
- Patient susceptibility to drug toxicity can vary significantly.
Observation:
- This case history highlights a patient's severe reaction to alkylating agents.
- The patient developed drug-induced pneumonitis.
- This reaction prompted further cardiac investigation.
Findings:
- The patient exhibited susceptibility to alkylating agents.
- Drug-induced pneumonitis was observed.
- Myocardial fibrosis and cardiac failure were diagnosed.
Implications:
- Clinicians should consider screening left ventricular function in patients with drug-induced pneumonitis.
- Early diagnosis of myocardial fibrosis can prevent cardiac failure.
- This underscores the importance of monitoring cardiac function during alkylating agent therapy.